Pregnancy and Medication Impact
Pregnancy and Medication Impact is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 25k research works in it since 1950. 21.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the effects of medication, particularly immunosuppressive drugs, on pregnancy outcomes, focusing on conditions such as inflammatory bowel disease, rheumatoid arthritis, and asthma. It covers topics such as medication use during pregnancy, placental transfer of drugs, impact on birth outcomes, fertility, and teratogenicity. Additionally, it delves into the management of nausea and vomiting in pregnancy and the safety of various medications for both mother and fetus.
- Pregnancy
- Medication Use
- Inflammatory Bowel Disease
- Rheumatoid Arthritis
- Birth Outcomes
- Immunosuppressive Drugs
- Fertility
- Asthma Exacerbations
- Teratogenicity
- Nausea and Vomiting
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 5.2k per year above
- Top-10% rate
- 21.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +44% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pregnancy and Medication Impact research?
By volume, the United States and China publish the most (1.1k and 577 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 577 works
- 3 United Kingdom 274 works
- 4 India 239 works
- 5 Canada 174 works
- 6 France 171 works
- 7 Indonesia 163 works
- 8 Türkiye 163 works
- 9 Germany 159 works
- 10 Japan 145 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pregnancy and Medication Impact research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Pregnancy and Medication Impact research, followed by Harvard University and University of Washington.
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 26 works
- 2 Harvard UniversityUnited States 21 works
- 3 University of WashingtonUnited States 17 works
- 4 University of California, San FranciscoUnited States 16 works
- 5 Sağlık Bilimleri ÜniversitesiTürkiye 15 works
- 6 University of TorontoCanada 15 works
- 7 King's College LondonUnited Kingdom 15 works
- 8 Karolinska InstitutetSweden 15 works
- 9 Icahn School of Medicine at Mount SinaiUnited States 14 works
- 10 Erasmus MCNetherlands 13 works
Who are the leading researchers in Pregnancy and Medication Impact?
The most-cited researchers publishing on Pregnancy and Medication Impact include Giuseppe Remuzzi.
- 1 Giuseppe Remuzzi Italy 8.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pregnancy and Medication Impact research done?
The largest centres of Pregnancy and Medication Impact research in 2022–2025 are London (United Kingdom), Paris (France), Beijing (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Rotterdam.
Largest cities, 2022–2025
Where it is the local speciality
- RotterdamNL · 22.3 works7.0×
Location quotient: how much more of its research is in Pregnancy and Medication Impact than the world average.
Where is the best place to study Pregnancy and Medication Impact?
Among universities, judged by research, Karolinska Institutet, Monash University and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska InstitutetSweden | 65.7 | 38.0% | 6.8× | 14 | +6.7% |
| 2 | Monash UniversityAustralia | 55.5 | 43.5% | 3.0× | 12 | +39.3% |
| 3 | Icahn School of Medicine at Mount SinaiUnited States | 55.0 | 29.8% | 6.0× | 14 | +81.9% |
| 4 | King's College LondonUnited Kingdom | 52.6 | 30.0% | 4.0× | 15 | +69.8% |
| 5 | Harvard UniversityUnited States | 50.0 | 25.2% | 3.5× | 21 | +30.2% |
| 6 | Stanford UniversityUnited States | 44.7 | 31.7% | 2.3× | 13 | +68.4% |
| 7 | University of California, San FranciscoUnited States | 44.2 | 20.3% | 5.3× | 16 | +31.0% |
| 8 | University of North Carolina at Chapel HillUnited States | 39.9 | 14.1% | 3.1× | 26 | +54.7% |
| 9 | University of California San DiegoUnited States | 39.0 | 19.9% | 2.8× | 12 | +126.4% |
| 10 | University of WashingtonUnited States | 38.1 | 20.0% | 3.4× | 17 | +18.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pregnancy and Medication Impact research growing?
Output in 2018–2022 was 44% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Pregnancy and Medication Impact.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.